Enzo Biochem (ENZ) Appoints Steven J. Pully to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- Boeing commercial jet deliveries and production disrupted by widespread IT outage - Air Current
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
October 30, 2023 4:15 PM EDTFARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Â Enzo Biochem, Inc. (NYSE: ENZ) (Enzo or the Company), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Companys Board of Directors effective October 26, 2023. Mr. Pully will assume the role of Chairperson of the Board, and Chair of the Audit Committee as well.
In 2023, Enzo completed the divestiture of Enzo Clinical Labs, Inc. and focused its strategy on growing the life sciences division, said Kara Cannon, Enzos Chief Executive Officer. Steve brings a unique portfolio of legal, corporate governance, and financial... More
